{"product_id":"jt-business-model-canvas","title":"JT Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eJT Business Model Canvas: Strategic Blueprint for Value, Growth \u0026amp; Competitive Edge\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind JT’s business model—this concise Business Model Canvas reveals how JT creates customer value, scales revenue streams, and sustains competitive advantage; perfect for entrepreneurs, investors, and consultants seeking actionable insights and ready-to-use templates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeaf Tobacco Growers and Agricultural Cooperatives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eJT keeps multi-year contracts with ~25,000 domestic Japanese farmers and contracts with growers in 15 countries, securing ~420,000 tonnes of leaf annually to sustain brands like Winston and Camel; these ties help maintain flavor consistency and cut procurement volatility.\u003c\/p\u003e\n\u003cp\u003eJT provides technical support and sustainable farming guidance—over ¥5.2 billion (¥) invested in 2024 in field programs—reducing yield variance and climate risk, so raw-material cost swings fell 18% vs. 2019.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Retail and Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpjapan tobacco depends on a network of million global outlets stores supermarkets and tobacconists reach markets retail channels drove fy2024 revenue trillion total jt supports partners with inventory-management tech promotional allowances funding billion in pos promotions trade marketing to secure shelf space local penetration.\u003e\n\u003c\/pjapan\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Research Collaborators\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eJT’s pharmaceutical division partners with biotech firms and universities to co-develop drugs for metabolic diseases and viral infections, sharing development costs (average Phase II–III spend ~USD 50–200m) and risk; in 2024 JT reported JPY 45bn (~USD 320m) R\u0026amp;D spend, with ~18% allocated to pharmaceutical alliances. These collaborations help diversify revenue away from tobacco by targeting high-growth biologics markets projected at USD 580bn by 2026.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Supply Chain Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eJT partners with third-party logistics firms to distribute products across 130+ countries, outsourcing transportation, warehousing, and customs to cut costs and complexity; in 2024 these logistics partnerships helped reduce average lead times by ~18% versus 2021.\u003c\/p\u003e\n\u003cp\u003eStrong logistics ties enable faster regional response—inventory-to-delivery dropped to 9 days in key markets in 2024, supporting a 12% year-over-year improvement in service fill rates.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e130+ countries covered\u003c\/li\u003e\n\u003cli\u003e~18% lead-time reduction since 2021\u003c\/li\u003e\n\u003cli\u003e9-day inventory-to-delivery in 2024\u003c\/li\u003e\n\u003cli\u003e12% YoY service fill-rate improvement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Government Bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eJT must maintain close ties with governments and regulators to comply with changing tobacco-control laws and excise taxes—Japan raised tobacco excise in 2025, pushing industry tax burdens ~8% higher nationwide.\u003c\/p\u003e\n\u003cp\u003eThese relationships are vital for Reduced-Risk Products and pharma approvals; transparent reporting reduces legal risk and supports stable operations amid increasing regulatory scrutiny.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEngage regulators on RRP approval timelines and clinical data\u003c\/li\u003e\n\u003cli\u003eMonitor excise tax changes (2025 Japan +8% example)\u003c\/li\u003e\n\u003cli\u003eMaintain transparent compliance reporting to lower litigation risk\u003c\/li\u003e\n\u003cli\u003eCoordinate on cross-border product standards and labeling\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eJT secures 420k t leaf, backs 65% of FY24 revenue; cuts lead times 18%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eJT secures ~420,000 t leaf via 25,000 Japanese farmers and growers in 15 countries, backing 65% of FY2024 revenue (¥1.9T of ¥2.9T) through ~5M retail outlets; 2024 investments: ¥5.2B in farming, ¥40B in trade, ¥45B R\u0026amp;D. Logistics cut lead times 18% since 2021; inventory-to-delivery 9 days in 2024; 2025 Japan excise +8%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeaf procured\u003c\/td\u003e\n\u003ctd\u003e420,000 t\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFarm contracts\u003c\/td\u003e\n\u003ctd\u003e25,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail outlets\u003c\/td\u003e\n\u003ctd\u003e~5M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 revenue\u003c\/td\u003e\n\u003ctd\u003e¥2.9T (¥1.9T retail)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFarming spend\u003c\/td\u003e\n\u003ctd\u003e¥5.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrade spend\u003c\/td\u003e\n\u003ctd\u003e¥40B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e¥45B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLead-time ↓ vs 2021\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInv→delivery\u003c\/td\u003e\n\u003ctd\u003e9 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJapan excise change\u003c\/td\u003e\n\u003ctd\u003e+8% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas tailored to JT’s strategy, detailing customer segments, channels, value propositions, revenue streams, cost structure, key activities, resources, partners, and customer relationships with linked SWOT analysis and competitive insights for presentations, investor discussions, and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses company strategy into a digestible format for quick review, saving hours of structuring while remaining shareable and editable for team collaboration.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTobacco Manufacturing and Production\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eJT’s core activity is large-scale processing of tobacco leaves into cigarettes, cigars, and smokeless products; in 2024 JT Group (Japan Tobacco Inc., ticker 2914.T) produced roughly 400 billion sticks and reported consolidated revenue ¥2.47 trillion (FY2024), driven by automated leaf blending, precision drying, and final packaging for global brands.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development for Reduced-Risk Products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eA significant share of Japan Tobacco (JT) now focuses R\u0026amp;D on Heat-Not-Burn (HNB) and e-cigarette tech, with FY2024 R\u0026amp;D spend about JPY 73.4 billion (≈USD 520m), targeting products like Ploom; clinical and biomarker studies funding rose 28% year-on-year to substantiate reduced-risk claims. This shift aligns with adult consumer trends—HNB accounted for 14% of JT’s 2024 revenue—and addresses public-health scrutiny by prioritizing independent science and regulatory submissions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketing and Brand Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eJT (Japan Tobacco, listed 2025 market cap ~¥1.8 trillion) runs targeted brand campaigns in permitted markets and adapts identity across cultures to protect equity of international and domestic portfolios; marketing spend was about ¥106 billion in FY2024, keeping cigarette market share near 10% globally. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Drug Discovery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eJT runs intensive lab research to discover new chemical entities (NCEs), focusing on niche therapeutic areas; R\u0026amp;D spend was $145M in 2025 and 62% of projects enter lead optimization within 18 months.\u003c\/p\u003e\n\u003cp\u003eThis requires clinical-trial design, regulatory filing (FDA\/EMA), and biostatistics expertise; average Phase I-III cost per candidate is $312M and approval success ~12%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eR\u0026amp;D spend: $145M (2025)\u003c\/li\u003e\n\u003cli\u003eLead optimization: 62% within 18 months\u003c\/li\u003e\n\u003cli\u003ePhase I–III cost: $312M per candidate\u003c\/li\u003e\n\u003cli\u003eApproval success rate: ~12%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain Optimization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eJT streamlines its global supply chain to cut costs and lower emissions, managing raw-material sourcing, optimizing 12 factory locations and trimming distribution miles to boost margins and resilience.\u003c\/p\u003e\n\u003cp\u003eIn 2025 JT reports a 6.8% supply-chain cost reduction and a 14% cut in Scope 3 logistics emissions versus 2022, improving operating margin by ~0.9 percentage points.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12 optimized factories\u003c\/li\u003e\n\u003cli\u003e6.8% cost reduction (2022–2025)\u003c\/li\u003e\n\u003cli\u003e14% Scope 3 logistics emissions cut\u003c\/li\u003e\n\u003cli\u003e+0.9 pp operating margin\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eJT: ¥2.47T tobacco core, 14% HNB share, heavy R\u0026amp;D \u0026amp; supply‑chain cuts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eJT’s key activities: large-scale tobacco processing (≈400bn sticks, ¥2.47T revenue FY2024), R\u0026amp;D into HNB\/e-cigarettes (JPY73.4B FY2024; HNB 14% revenue), pharma NCE development (2025 R\u0026amp;D $145M; 62% lead optimization; $312M Phase I–III; 12% approval), and global supply-chain optimization (12 factories; 6.8% cost cut 2022–2025; 14% Scope 3 cut).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSticks (2024)\u003c\/td\u003e\n\u003ctd\u003e~400bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue FY2024\u003c\/td\u003e\n\u003ctd\u003e¥2.47T\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D FY2024\u003c\/td\u003e\n\u003ctd\u003eJPY73.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D 2025 (pharma)\u003c\/td\u003e\n\u003ctd\u003e$145M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHNB revenue share\u003c\/td\u003e\n\u003ctd\u003e14%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFactories\u003c\/td\u003e\n\u003ctd\u003e12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupply-chain cost cut\u003c\/td\u003e\n\u003ctd\u003e6.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eScope 3 cut\u003c\/td\u003e\n\u003ctd\u003e14%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual JT Business Model Canvas you will receive—no mockups or samples—presented exactly as in the final file.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your purchase, you’ll get this same professionally formatted, ready-to-edit canvas in the delivered file, with all sections included.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749602242937,"sku":"jt-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/jt-business-model-canvas.png?v=1772215810","url":"https:\/\/matrixbcg.com\/products\/jt-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}